A B S T R A C T This study was designed to define quantitatively the function of the rat glomerular mesangium in the uptake and processing of intravenously administered protein macromolecules (radiolabeled aggregated human IgG, AHIgG-'I), to relate this function to that of the general reticuloendothelial system, and to examine the effects of increased glomerular permeability to protein on the mesangial cell system.
Mesangial localization of human IgG as demonstrated by immunofluorescent microscopy showed good correlation with concentrations of AHIgG-;I in preparations of isolated glomeruli. In normal rats the concentrations of AHIgG-'I in glomeruli were similar to those of lung, liver, and spleen and demonstrated a rapid decrease with increasing time intervals after aggregate administration.
In rats given aminonucleoside of puromycin a marked increase in mesangial uptake of aggregates was found while studies of nephrotic lungs, liver, spleen, and blood showed no such differences. Glomerular levels of AHIgG-'I in aminonucleoside animals could not be correlated with the quantity of proteinuria.
Nephrotic and control animals given unaggregated human IgG showed little glomerular localization by immunofluorescent microscopy; no difference in the concentration of this protein in nephrotic as compared to control glomerular isolates was found.
Thus, the mesangium in normal animals functions in a manner analogous to that of the general reticuloendothelial system. In nephrotic rats the mesangial uptake
INTRODUCTION
The mesangium is a poorly understood part of the glomerulus occupying, in man, approximately 8% of the glomerular surface area and containing 25% of the total number of glomerular cells (1) . The mesangial cells occupy an intercapillary position separated from the capillary lumen, internally, by the endothelial cell cytoplasm and bounded externally by the glomerular basement membrane (2) . Light, immunopathologic, and electron microscopic observations of the human kidney in a variety of diseases including anaphylactoid purpura nephritis (3) , chronic membranoproliferative nephritis with hypocomplementemia (4), diabetic nephropathy (5) , acute poststreptococcal nephritis (6) , and lupus erythemnatosis (7) have demonstrated significant mesangial alterations. However, at present only very limited knowledge of the function of the mesangial system and its relationship to glomerular pathology is available.
Studies of the glomerular localization and transport of macromolecular tracer materials including thorotrast (8) , ferritin (2) , colloidal carbon (9) , and globin (10) have demonstrated mesangial uptake of these substances after their injection into the circulation of normal animals. Thus, Farquhar and Palade have suggested that one function of the mesangium is the removal of filtration residues from the subendothelial space (2). More recently, Michael, Fish, and Good (11) showed that aggregated human gamma globulin, a polydisperse population of macromolecules having many of the properties of antigen-antibody complexes (12) , localizes in the mouse glomerulus after intravenous injection. Immunofluorescent studies demonstrated that, within a few hours, there was transport of these aggregates to the mesangial region from which they gradually disappeared over the next 36-72 hr.
The purpose of this paper is to describe a method of quantitating mesangial macromolecular uptake and to describe the effects on this mechanism of increased glomerular permeability to protein as induced by aminonucleoside of purornycin (PA).' We found that mesangial function in normal rats is similar to that of the general reticuloendothelial system, whereas nephrotic animals demonstrate increased mesangial macromolecular uptake.
METHODS
Preparation of radiolabeled aggregated human gamma globulin and nonaggregated human gamma globulin Human immune serum globulin' (Cohn fraction II), kindly provided by the American National Red Cross, was labeled with 125" 3 by the chloramine-T' method of McConahey and Dixon (13) with one modification as suggested by these authors,' i.e., 0.15 M phosphate buffer pH 7.0 was employed instead of 0.05 M phosphate buffer. 1 mCi of 'I was used to label each 25 mg of human IgG; 1.0 g of unlabeled human IgG was added at the end of the labeling procedure before removal of free '2I on a 30 ml Dowex 1-X8 (100-200 mesh) column.' The efficiency of labeling was approximately 55 % and the quantity of free 'tI in the final product was less than 3%. From this labeled protein heat-aggregated human IgG was prepared according to the methods of Christian (14, 15) and Ishizaka, Salmon, and Fudenberg (12) with certain modifications. To each 100 ml of a 2% human IgG solution, in 0.15 M saline buffer containing 0.01 M sodium phosphate (phosphate-saline buffer), approximately 0.2 mCi of labeled protein was added. This mixture was then heated to 630C for 30 min and cooled to room temperature. 40 ml of 2.18 M sodium sulphate was added and the mixture was stirred for 30 min. From this point on all procedures were carried out at 4VC. The resulting precipitate obtained by centrifugation at 3000 g for 30 min was resuspended in small quantities of cold phosphatesaline buffer and dialyzed against this buffer for 24 hr with three bath changes. The dialyzed protein solution was centrifuged at 104,000 g for 90 min and the pellet was resuspended in cold buffer and centrifuged at 5000 g to remove insoluble protein aggregates. The concentration of the aggregated human IgG-'I (AHIgG-2IJ) was determined by the biuret reaction and adjusted to contain 25 mg of protein per milliliter and merthiolate was added to a final concentration of 1:10,000. 
Experimental design
Kinetic studies of mesangial function in normal and nephrotic rats. Nine groups of 10 rats each (male, SpragueDawley, 100 g) were given daily subcutaneous injections of 1.5 mg of PA' in 1.0 ml of 0.9 M NaCl for 10 days and for each of these groups an additional 10 rats served as controls. After the last injection, all aminonucleoside animals had marked proteinuria and were clinically nephrotic. 24 hr after. the last PA dose, the nephrotic animals and their concurrent controls were each given AHIgG-'25I in a dose of 0.25 mg per gram body weight by tail vein injection. Phenergan was administered intraperitoneally to the animals 5 min before the AHIgG-"I injection in a dose of 0.005 mg per gram body weight, since this was shown to decrease the incidence of death after aggregate administration. Nephrotic and control animals were sacrificed in groups of 10 at 1, 2, 4, 16, 36, and 72 hr and 1 wk (168 hr) after aggregate administration. Two groups of 10 nephrotic and 10 control animals each were studied 8 hr after AHIgG-"'I injection. All the animals survived the aggregate injection except for four aminonucleoside animals in the 36 hr group.
The relationship of mesangial function, to proteinuria in rats with aminonuicleoside nephrosis. Three groups of 10 rats each were given daily subcutaneous injections of 1.5 mg of PA. The first group received PA for 4 days, the second for 6 days, and the third for 10 days. 30 animals in three groups of 10 rats each served as concurrent controls. Urine was collected from PA and control animals by placing them in metabolic cages without food but with free access to water for 24 hr. The cages were rinsed with water and values for 24 hr urinary excretion of protein from this total collection were determined by the biuret reaction on trichloroacetic acid (TCA)-precipitable protein (16) . The animals were then given AHIgG-5I in a dose of 0.25 mg per gram body weight intravenously and sacrificed 8 hr later by cervical dislocation.
Nonaggregated protein injection in normal and nephrotic rats. 20 animals were given PA for 10 days and were then injected intravenously with NAHIgG-"I in a dose of 0.25 mg per gram body weight. 20 normal rats served as controls and received only the NAHIgG-.I injections. All animals in this experiment were sacrificed at 8 hr after NAHIgG-"'I administration.
Immunofluorescent studies
Immediately after sacrifice the kidneys were removed and a cortical slice was placed in formalin for paraffin embedding and subsequent staining with hematoxylin and eosin and periodic acid-Shiff (PAS) reaction. Part of the kidney was immediately frozen in isopentane precooled in liquid nitrogen, sectioned at 4 / in a Lipshaw cryostat, and processed for immunofluorescence with appropriate controls according to methods previously described (6) using fluorescein-isothiocyanate-labeled rabbit antisera against human 'Nutritional Biochemicals Corporation, Cleveland, Ohio.
IgG. The amount of immunofluorescence was arbitrarily graded as negative, trace, 1+, 2+, 3+, and 4+; photographs were taken as previously described (6).
Glomerular isolation
Each glomerular isolate was prepared from a pool of the kidneys of five PA or control animals as previously described (17) . A mash of decapsulated kidneys was pushed through a 150 mesh monel screen,8 the resulting suspension was poured through a 100 monel screen to exclude large tissue fragments and tubules, and the glomeruli were collected on a 200 mesh screen, washed vigorously with a jet of 0.15 Mf sodium chloride, and rinsed into a 50 ml centrifuge tube. An aliquot was examined by phase contrast microscopy to ensure that at least 85% purity of the preparation was obtained. The glomeruli were then washed four times with distilled water, lyophilized, weighted, and counted in a crystal scintillation counter for "I. The data were expressed as micrograms AHIgG-'25I per milligram dried glomeruli plus or minus standard error. In four homogenized glomerular preparations more than 98% of the counts were precipitable by TCA.
Preparation of lung, liver, spleen, and blood for counting for "I Samples of lung, liver, and spleen were obtained from each animal at the time of sacrifice. These tissues were washed twice in isotonic saline, dried in a ventilated oven overnight at 850C, weighed, and dissolved in Blood was obtained by cardiac puncture in ether-anesthetized animals just before sacrifice. 50-or 100-1ul whole blood samples were added to 2.0 ml of 0.1% sodium carbonate to produce hemolysis. After total counts for 125I were obtained, 2.0 cc of 10% TCA was added to produce protein precipitation. The samples were centrifuged at 5000 g and the supernatant separated and counted to determine free 125I; protein-bound counts were calculated by subtraction.
RESULTS
Kinetic studies of mesangial function in normal and nephrotic rats Imnnolulnoforescent microscopy. All aminonucleoside rats in this experiment received PA for 10 days.
Nephrotic and control rats were sacrificed at intervals of from 1 to 168 hr after AHIgG-'I administration.
At 1 hr all animals studied had human IgG widely distributed within the glomerular and peritubular capillaries. The glomerular staining appeared to be localized to the capillary lumen, probably in a subendothelial location ( Fig. la) . At 2 hr little peritubular and glomerular capillary luminal staining was evident and IgG was present along the endothelium and within the mesangium. By 4 hr human IgG was found almost entirely within the 8'Michigan-Dynamics, Inc., Detroit, Mich. glomeruli and in a mesangial distribution with staining in the center of the glomerular lobules in an arborizing pattern which radiated toward the glomerular hilum in the region of the afferent and efferent arteriole. Rarely, arteriolar staining was seen (Fig. lb) ; no fluorescence was seen in peritubular capillaries, tubular lumina, Bowman's space, in the area of the capillary loop, or within or along the glomerular basement membrane (GBM). Thus from 4 to 168 hr the results in Table I may be considered as a comparison, between PA and control kidneys, of the intensity of mesangial deposits of IgG. These results reveal increased mesangial localization of human IgG at each of the time periods from 4 to 168 hr ( Fig. Ic and d) . As the intensity of mesangial fluorescence diminished with time the axial and central portion of the mesangium lost the staining more rapidly, leaving only the peripheral areas positive for IgG ( Fig. le and f) .
Gloinerular isolations. Glomerular levels of AHIgG-I5I were similar in control and nephrotic animals sacrificed 1 hr after aggregate administration (Fig. 2) . Thereafter levels in nephrotic glomeruli were consistently higher than control values. The AHIgG-1'I content of nephrotic glomeruli rose steadily during the early hours after injection to peak at 8 hr at a mean (four preparations) of 5.04+0.57 iug AHIgG-l'I per mg glomeruli; control values generally fell over this time period to a mean (four preparations) of 0.535±0.025 ug AHIgG-1"I per mg glomeruli.
After 8 hr there were no differences between the falloff slope derived from the data of the PA glomerular isolates (-1.232±0.137) and that of control preparations (-0.856+0.206) (0.1 < P < 0.2).
Lung, liver, spleen, and blood. During the first 8 hr after the administration of AHIgG-"1J, at a time when there were striking differences in glomerular uptake between control and PA animals, there were no significant differences in lung, liver, or spleen uptake (Fig. 2) . At subsequent time periods slight differences (P < 0.01) were seen only at 168 hr in lung (control values higher than PA) and at 36 hr in liver (PA values higher than control).
Blood levels of aggregates decreased rapidly from the values at 1 hr so that by 8 hr only 4.9% of the 1-hr level was still circulating in PA animals and 5.2% in control. Significant differences did not occur at the 1-, 2-, 4-, or 8-hr time periods (Fig. 3) . However at 16, 36, 72, and 168 hr blood levels in PA animals were consistently and significantly lower than those in control rats (P < 0.001).
Comparison of falloff rates from lung, liver, spleen, and blood. Simple linear regression analyses of falloff slopes derived from data for lung, liver, spleen, and blood from the 8-to 168-hr time periods showed no (Fig. Id) . The tubular staining seen above the glomerulus represents autofluorescence.
significant differences between tissues of PA and con-significantly from controls (P < 0.001). After 10 days trol groups.
of PA administration all rats were clinically nephrotic and the mean urinary protein excretion was more than Relationship of mesangial function to proteinuria 60 times that of controls (Table II) Glomerular levels of AHIgG-"'I. Values for AHIgG-"I in glomeruli isolated from 4-, 6-, and 10-day aminonucleoside rats were considerably higher than those obtained from control animals (Table II) (Table II) .
AHIgG-"'I in lung, liver, spleen, and blood. There were no significant differences in the levels of AHIgG-1'5I in liver, spleen, or blood on comparing 4-day aminonucleoside animals with controls (Table III) . The level in the lungs of control animals in the 4 day PA experiment were higher than control (0.001 < P < 0.005).
In the 6 day PA experiment lung, spleen, and blood studies showed no differences; however the AHIgG-'I level in the liver of nephrotic animals was higher than controls (0.001 < P < 0.005) ( Table III) (Table IV) . No differences were found in liver, spleen, or -blood values but there was a silghtly higher concentration of NAHIgG-'I in the lungs of nephrotic rats (P < 0.01). DISCUSSION The mesangial or "third cell" system of the glomerulus has been well defined anatomically as occupying a strategic intercapillary position in the glomerular stalk with cytoplasmic processes extending for some distance and in several directions between the endothelial cell and the GBM (2) . Individual mesangial cells are separated from one another by amorphous fibrillar PAS-positive material of unknown composition, the mesangial matrix. Despite the important involvement of this cell system in several pathological states little is known of its functional significance. Substances entering the glomerulus via the afferent arteriole may be filtered, excluded and passed into the efferent arteriole, or may be "trapped" in the glomerulus in or along the GBM, or may pass into the mesangium. The study of the mesangial mechanisms involved in the glomerular handling of macromolecular substances has previously been approached by anatomical techniques (2, 8, 9, 10, 11) . In this report an attempt was made to apply quantitative methodology to the examination of the kinetics of mesangial uptake (afferent Mesangial Macromolecular Uptake in Normal and Nephrotic Rats T The PA and control groups contain 10 rats each. The numbers represent the number of animals per group with a given intensity of fluorescence on a scale of 1 + to 4 +. § Each value represents the concentration of AHIgG-125I in one glomerular isolation from a pool of kidneys of five animals. All animals were sacrificed 8 hr after AHIg-125I administration. (24) demonstrated that, in rabbits developing acute serum sickness nephritis, cortisone inhibited the development of glomerulitis and immune complexes localized preferentially in the mesangium as opposed to the subepithelial portion of the capillary loop. These authors theorized that the effect of cortisone was to diminish glomerular basement membrane permeability to circulating immune complexes thus preventing transmigration of these complexes across the filtration barrier for plasma proteins. Our studies clearly demonstrate that increased permeability to protein in aminonucleoside nephrosis is associated with increased mesangial uptake of circulating macromolecules.
It is known that the administration of aminonucleoside results, in most rats, in chronic renal disease with progressive mesangial hyperplasia and lobular sclerosis (25) , which is associated with mesangial deposition of host (rat) immunoglobulins and to a lesser extent, complement components (26, 27) . It is possible that in these animals endogenous circulating immune complexes gain access to the mesangium and eventually produce chronic changes. Focal sclerosis, mesangial proliferative changes, stalk hyalinization, and, eventually, glomerular fibrosis can occur in human glomerulonephritis and nephrotic syndrome. Although there is no direct way of measuring mesangial function in man, the further application of quantitative techniques to the study of mesangial function in animals may provide insights into the relationships between the mesangial cell system and glomerular disease.
